Early Detection Research Network

Lung

Reports have demonstrated that MIF expression is increased in premalignant, malignant, and metastatic tumors and a potential therapeutic target in NSCLC.
http://edrn.jpl.nasa.gov/bmdb/biomarkers/organs/81/919
Under Review
One
MIF belongs to a 9-member panel that provides a quantitative measure of the probability of having lung cancer that goes beyond the histological evaluation of preinvasive lesions. The identified members of the panel are TMSB4X (Thymosin beta-4), Ubiquitin, des-ubiquitin, ACBP, CSTA, Cytochrome C, and MIF.
0047332af278485096ce50b05280ef2f
no
no
Contents

There are currently no items in this folder.